Natural history of hypertension subtypes

Circulation

Volumn 111, Issue 9, 2005, Pages 1094-1096

  Verdecchia, Paolo ^a   Angeli, Fabio ^a  

^a Ospedale Silvestrini   (Italy)

Author keywords

Blood pressure; Editorials; Epidemiology; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AORTA; ARTERY RESISTANCE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DIASTOLIC HYPERTENSION; DISEASE CLASSIFICATION; EDITORIAL; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; MEDICAL LITERATURE; ONSET AGE; PRIORITY JOURNAL; SYSTODIASTOLIC HYPERTENSION; SYSTOLIC HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; COMORBIDITY; DIASTOLE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; RISK FACTORS; SMOKING; STROKE VOLUME; SYSTOLE; VASCULAR RESISTANCE;

EID: 14944376217     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000158690.78503.5F     Document Type: Editorial

References (22)

1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
2. Franklin SS. New interpretation of blood pressure: the importance of pulse pressure. In: Oparil S and Weber MA, eds. Hypertension: A Companion to Brenner and Rector's The Kidney. St Louis. Mo: W.B. Saunders; 2000:227-234.
3. Smulyan H, Safar ME. Systolic blood pressure revisited. J Am Coll Cardiol. 1997;29:1407-1413.
4. O'Rourke MF. Arterial Function in Health and Disease. Edinburgh, UK: Churchill Livingston; 1982.
5. Fang J, Mafhavan S, Cohen H, Alderman MH. Isolated diastolic hypertension: a favourable finding among young and middle-aged hypertensive subjects. Hypertension. 1995;26:377-382.
6. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
7. Franklin SS, Gustin W IV, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315.
8. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H, Hofman A. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343:504-507.
9. Pickering TG. Isolated diastolic hypertension. J Clin Hypertens. 2003;5:411-413.
10. Nielsen WB, Lindenstrom E, Vestbo J, Jensen GB. Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens. 1997;10:634-639.
11. Petrovitch H, Curb JD, Bloom-Marcus E. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke. 1995;26:25-29.
12. Strandberg TE, Saloman VV, Vanhanen HT, Pitkala K, Miettinen TA. Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of tip to 32 years. J Hypertens. 2002;20:399-404.
13. Lloyd-Jones DM, Evans JC, Larson M, O'Donnel CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594-599.
14. Hansson L, Zanchetti A, Carruthers G, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn CH, Wedel H, Westerling S, for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
15. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2897.
16. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ, CONVINCE Research Group. Principal results of the Controlled ONset Verapamil Investigation of Cardiovascular Endpoints (CONVINCE) Trial. JAMA. 2003;289:2073-2082.
17. Benetos A, Bean TK, Gaurier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. 2002;102:577-581.
18. Franklin SS, Pio JR, Wong ND, Larson MG, Leip EP, Vasan RS, Levy D. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation. 2005;111:1121-1127.
19. Bulpitt CJ, Palmer AJ, Fletcher AE, Bradley IC, Broxton JS, Davis AJ, Ganvir PL, Gostick NK, Mayhew SR, Mukerji D. Proportion of patients with isolated systolic hypertension who have burned-out diastolic hypertension. J Hum Hypertens. 1995;9:675-678.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, and the National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
21. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345:1291-1297.
22. Thomas RJ, Kottke TE, Brekke MJ, Brekke LN, Brandel CL, Aase LA, DeBoer SW. Attempts at changing dietary and exercise habits to reduce risk of cardiovascular disease: who's doing what in the community? Prev Cardiol. 2002;5:102-108.